* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can...
MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- The University of Texas MD Anderson Cancer Cen...
* Radiopharm will shortly initiate a PD-L1 Phase 1 therapeutic study in Australia in patients wit...
* Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university,...